New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

Fact checked by Nick Blackmer New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%.

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire Arthrosi Therapeutics, a startup with a gout drug candidate in Phase 3 ...

That's according to a new study presented at the American Academy of Orthopedic Surgeons annual meeting.

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and ...